 Molecular evaluation response all-trans-retinoic acid therapy patients acute promyelocytic leukemia advent retinoic acid RA treatment acute promyelocytic leukemia APL high frequency short-lasting complete remissions CR response RA RA receptor alpha RAR locus APLs Southern blot analysis RAR alpha rearrangements APL samples myeloid cells weeks start RA treatment weeks patients CR investigations clear evidence CR molecular level reconstitution normal nonclonal hematopoiesis RA acts differentiation cytotoxic effect leukemic clone